Koninklijke Philips NV ADR (PHG)
NYSE · Healthcare · Medical Devices
Koninklijke Philips NV ADR is a Healthcare company with a market capitalization of $26.34B, a trailing P/E ratio of 23.8, and a dividend yield of 3.74%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.27 | $0.19 | +42.1% |
| Q4 2025 | February 10, 2026 | $0.71 | $0.50 | +42.0% |
| Q3 2025 | November 4, 2025 | $0.41 | $0.32 | +28.1% |
| Q2 2025 | July 29, 2025 | $0.42 | $0.29 | +44.8% |
| Q1 2025 | May 6, 2025 | $0.28 | $0.14 | +100.0% |
| Q4 2024 | February 19, 2025 | $0.51 | $0.60 | -15.0% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Koninklijke Philips NV ADR's market cap?
As of June 29, 2026, Koninklijke Philips NV ADR (PHG) has a market capitalization of $26.34B.
What is Koninklijke Philips NV ADR's P/E ratio?
Koninklijke Philips NV ADR trades at a trailing price-to-earnings (P/E) ratio of 23.8. Its forward P/E is 15.2.
Does Koninklijke Philips NV ADR pay a dividend?
Yes — Koninklijke Philips NV ADR pays a dividend yielding 3.74%, an annual payout of $0.85 per share.
What sector is PHG in?
Koninklijke Philips NV ADR is in the Healthcare sector, specifically the Medical Devices industry.
What was Koninklijke Philips NV ADR's revenue?
In its latest reported fiscal year (ending December 31, 2025), Koninklijke Philips NV ADR reported revenue of $17.83B and net income of $895.00M.
Ask your own questions about PHG
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.